Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy

Abstract Objective Currently, the application of single-port inflatable mediastinoscopic esophagectomy in patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant chemoimmunotherapy is relatively rare. This study aims to compare the clinical efficacy of single-port inf...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaishang Zhang, Guoqing Zhang, Yujin Qiao, Peng Zhang, Xiaofang Chen, Xue Pan, Xiangnan Li
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-14530-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769009540497408
author Kaishang Zhang
Guoqing Zhang
Yujin Qiao
Peng Zhang
Xiaofang Chen
Xue Pan
Xiangnan Li
author_facet Kaishang Zhang
Guoqing Zhang
Yujin Qiao
Peng Zhang
Xiaofang Chen
Xue Pan
Xiangnan Li
author_sort Kaishang Zhang
collection DOAJ
description Abstract Objective Currently, the application of single-port inflatable mediastinoscopic esophagectomy in patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant chemoimmunotherapy is relatively rare. This study aims to compare the clinical efficacy of single-port inflatable mediastinoscopic esophagectomy with that of thoracoscopic esophagectomy for locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy. Methods We retrospectively analyzed the perioperative data of 118 patients who underwent minimally invasive esophagectomy. Among them, 80 patients underwent thoracoscopy esophagectomy, and 38 patients underwent single-port inflatable mediastinoscopy esophagectomy. The number of mediastinal lymph nodes dissected, incidence of postoperative complications, and survival period were compared between the two groups. Results The results revealed that the number of mediastinal lymph nodes dissected was similar between the two groups (p = 0.185); In terms of postoperative complications, the incidence of pneumonia was significantly lower in the single-port inflatable mediastinoscopic esophagectomy group than in the thoracoscopic esophagectomy group (p = 0.038), but the incidence of hoarseness was higher in the single-port inflatable mediastinoscopic esophagectomy group than in the thoracoscopic esophagectomy group (p = 0.049). Moreover, there were no significant differences in recurrence patterns, overall survival, or disease-free survival between the two groups. Conclusions The results suggest that single-port inflatable mediastinoscopic esophagectomy is a safe and reliable option for patients with locally advanced esophageal squamous cell carcinoma who have received neoadjuvant chemoimmunotherapy.
format Article
id doaj-art-2f048afcb9ad4b2d82e03db73d6a0c35
institution DOAJ
issn 1471-2407
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-2f048afcb9ad4b2d82e03db73d6a0c352025-08-20T03:03:37ZengBMCBMC Cancer1471-24072025-07-012511910.1186/s12885-025-14530-0Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapyKaishang Zhang0Guoqing Zhang1Yujin Qiao2Peng Zhang3Xiaofang Chen4Xue Pan5Xiangnan Li6Department of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical UniversityNursing College of Zhengzhou University, Zhengzhou UniversityDepartment of Thoracic Surgery and Esophageal Surgery, The First Affiliated Hospital of Zhengzhou UniversityAbstract Objective Currently, the application of single-port inflatable mediastinoscopic esophagectomy in patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant chemoimmunotherapy is relatively rare. This study aims to compare the clinical efficacy of single-port inflatable mediastinoscopic esophagectomy with that of thoracoscopic esophagectomy for locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy. Methods We retrospectively analyzed the perioperative data of 118 patients who underwent minimally invasive esophagectomy. Among them, 80 patients underwent thoracoscopy esophagectomy, and 38 patients underwent single-port inflatable mediastinoscopy esophagectomy. The number of mediastinal lymph nodes dissected, incidence of postoperative complications, and survival period were compared between the two groups. Results The results revealed that the number of mediastinal lymph nodes dissected was similar between the two groups (p = 0.185); In terms of postoperative complications, the incidence of pneumonia was significantly lower in the single-port inflatable mediastinoscopic esophagectomy group than in the thoracoscopic esophagectomy group (p = 0.038), but the incidence of hoarseness was higher in the single-port inflatable mediastinoscopic esophagectomy group than in the thoracoscopic esophagectomy group (p = 0.049). Moreover, there were no significant differences in recurrence patterns, overall survival, or disease-free survival between the two groups. Conclusions The results suggest that single-port inflatable mediastinoscopic esophagectomy is a safe and reliable option for patients with locally advanced esophageal squamous cell carcinoma who have received neoadjuvant chemoimmunotherapy.https://doi.org/10.1186/s12885-025-14530-0ESCCNeoadjuvant chemoimmunotherapySpIMETESurgery
spellingShingle Kaishang Zhang
Guoqing Zhang
Yujin Qiao
Peng Zhang
Xiaofang Chen
Xue Pan
Xiangnan Li
Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
BMC Cancer
ESCC
Neoadjuvant chemoimmunotherapy
SpIME
TE
Surgery
title Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
title_full Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
title_fullStr Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
title_full_unstemmed Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
title_short Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
title_sort comparison of single port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
topic ESCC
Neoadjuvant chemoimmunotherapy
SpIME
TE
Surgery
url https://doi.org/10.1186/s12885-025-14530-0
work_keys_str_mv AT kaishangzhang comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT guoqingzhang comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT yujinqiao comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT pengzhang comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT xiaofangchen comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT xuepan comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy
AT xiangnanli comparisonofsingleportinflatablemediastinoscopicesophagectomyandthoracoscopicesophagectomyinpatientswithesophagealsquamouscellcarcinomaafterneoadjuvantchemoimmunotherapy